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https://doi.org/10.1016/j.molcel.2020.12.025SUMMARYCells have evolved an elaborate DNA repair network to ensure complete and accurate DNA replication. De-
fects in these repair machineries can fuel genome instability and drive carcinogenesis while creating vulner-
abilities that may be exploited in therapy. Here, we use nascent chromatin capture (NCC) proteomics to char-
acterize the repair of replication-associated DNA double-strand breaks (DSBs) triggered by topoisomerase 1
(TOP1) inhibitors. We reveal profound changes in the fork proteome, including the chromatin environment
and nuclear membrane interactions, and identify three classes of repair factors according to their enrichment
at broken and/or stalled forks. ATM inhibition dramatically rewired the broken fork proteome, revealing that
ataxia telangiectasia mutated (ATM) signalling stimulates DNA end resection, recruits PLK1, and concomi-
tantly suppresses the canonical DSB ubiquitination response by preventing accumulation of RNF168 and
BRCA1-A. This work and collection of replication fork proteomes provide a new framework to understand
how cells orchestrate homologous recombination repair of replication-associated DSBs.INTRODUCTION
Maintenance and inheritance of genomic and epigenomic infor-
mation is fundamental for genome stability and function in eu-
karyotes (Alabert and Groth, 2012). Replication stress threatens
genome stability and drives cancer development and progres-
sion (Macheret and Halazonetis, 2015), and cells have evolved
an elaborate network of DNA repair mechanisms to counter
this threat. Endogenous sources of replication stress include
oncogenic signaling, reactive oxygen species, replication-tran-
scription collisions, DNA secondary structures such as G-quad-
ruplexes, DNA and protein crosslinks, and deoxyribonucleotide1084 Molecular Cell 81, 1084–1099, March 4, 2021 ª 2020 The Autho
This is an open access article under the CC BY-NC-ND license (http://triphosphate (dNTP) exhaustion (Zeman and Cimprich, 2014).
Replication stress can also be induced by a wide range of exog-
enous genotoxic agents (Zeman and Cimprich, 2014), many of
which are potent chemotherapeutic agents (Lecona and Fernán-
dez-Capetillo, 2014). Replication stress responses are therefore
attractive targets for cancer therapy, with the potential to
develop more effective and targeted treatment as well as over-
come chemotherapy resistance.
Replication stress refers broadly to replication fork challenges,
but it is becoming increasingly clear that fork repair mechanisms
are highly tailored toward specific types of damage and replica-
tion intermediates (Cortez, 2019). The highly specialized forkrs. Published by Elsevier Inc.
creativecommons.org/licenses/by-nc-nd/4.0/).
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OPEN ACCESSArticlerepair mechanisms act in concert with shared global protective
responses that include dormant origin firing and cell cycle
checkpoints. Key replication fork-associated repair mechanisms
include fork reversal and nascent strand protection, translesion
synthesis, mismatch repair, lesion skipping/bypass and reprim-
ing, break-induced replication, and homologous recombination
(HR) (Cortez, 2019), which have differing prevalence toward
distinct fork damage. The interplay of these repair processes
and how they are regulated in response to different types of repli-
cation stress remains to be fully understood. Proteomics anal-
ysis of replication forks by isolation of proteins on nascent
DNA (iPOND) has uncovered a large number of repair and check-
point signaling factors recruited in response to hydroxyurea
(HU)-induced nucleotide depletion that stalls fork progression
(Dungrawala et al., 2015). The repair proteome of DNA inter-
strand crosslink (ICL) repair has also been characterized using
cell-free DNA replication in Xenopus egg extracts (R€aschle
et al., 2015). However, protein dynamics at replication forks chal-
lenged by topoisomerase 1 (TOP1) inhibitors has not been sys-
tematically characterized despite their widespread clinical use
to treat colorectal, lung, ovarian, cervical, and pancreatic can-
cers (Thomas and Pommier, 2019). TOP1 relaxes positive super-
coiling ahead of DNA and RNA polymerases and enables DNA
translocation during replication and transcription. TOP1 gener-
ates a single-stranded DNA (ssDNA) nick by formation of a tran-
sient TOP1-DNA cleavage complex (TOP1cc) that self-resolves
to religate the DNA strand. TOP1 inhibitors, such as camptothe-
cin (CPT), bind the interface of TOP1cc and prevent reversal, re-
sulting in a unique type of ssDNA break associated with DNA-
protein crosslinks (DPCs) that block DNA metabolic processes.
Upon replisome encounter, such lesions generate highly toxic
replication-associated single-ended double-strand breaks
(seDSBs), referred to as replication fork breakage (Ray Chaud-
huri et al., 2012; Thomas and Pommier, 2019). seDSBs are re-
paired primarily by HR (Arnaudeau et al., 2001), and a hallmark
of HR-deficient tumors is exquisite sensitivity to TOP1 inhibitors,
probably because of toxic non-homologous end joining (NHEJ)
(Adachi et al., 2004; Balmus et al., 2019; Thomas and Pommier,
2019). How the balance of HR over NHEJ is achieved at seDSBs
remains unclear, although ataxia telangiectasia mutated (ATM)
signaling and the BRCA1-A complex have recently been found
to be involved in pathway choice (Balmus et al., 2019).
We performed a comprehensive investigation of protein dy-
namics at replication forks challenged by CPT to determine the
broken fork proteome and its unique regulation of repair pathway
choice. As a discovery approach, we used nascent chromatin
capture (NCC) for comprehensive isolation of proteins enriched
at replication forks and nascent chromatin (Alabert et al., 2014;
Cortez, 2017). We combined NCC with stable isotope labeling
by amino acids in cell culture (SILAC) (Ong et al., 2002) to quan-
titatively identify proteome dynamics in response to replication-
associated seDSBs by mass spectrometry (NCC-SILAC-MS).
ComparingCPTandHU replication fork proteomes,we identified
three classes of fork repair factors according to their recruitment
dynamics in response to replication fork breakage upon CPT
treatment and fork stalling in response to HU. ATM was specif-
ically recruited to broken forks, consistent with the presence of
seDSBs. NCC-SILAC-MS showed extensive rewiring of thebroken fork repairome upon ATM inhibition, revealing that this
master kinase promotes recruitment of HR factors while sup-
pressing the canonical DSB ubiquitination responses and
NHEJ. We also demonstrated the value of our large datasets as
a resource for discovery of novel DNA repair factors by identifying
NDRG3 and UBAP2 as novel HR factors required for CPT resis-
tance. This provides a new framework to understand seDSB
repair as well as cancer vulnerabilities and resistance mecha-
nisms relevant for clinical use of TOP1 inhibitors.
RESULTS
Protein composition of broken replication forks
To characterize the broken fork proteome, we used CPT, a clin-
ically relevant and well-described inducer of seDSBs (Thomas
and Pommier, 2019). We treated cells with CPT and purified
replication forks by NCC. To maximize the number of replication
forks encountering a lesion and minimize secondary effects, S
phase-synchronized cells were briefly exposed to a high dose
of CPT, conditions known to induce replication-dependent
DSBs (Hsiang et al., 1989; Neelsen and Lopes, 2015; Ray
Chaudhuri et al., 2012; Thomas and Pommier, 2019). This treat-
ment induced a large number of lesions while only moderately
reducing DNA synthesis (Figure S1A). To achieve comparable
biotin-dUTP (b-dUTP) incorporation in control and CPT-treated
cells, we slightly extended the labeling time for CPT samples
(Figure 1A; Figure S1B). Analysis of fork composition by immuno-
blotting showed CPT-specific phosphorylation of histone H2AX
at Ser139 (gH2AX) and RAD51 recruitment, validating our strat-
egy for isolation of CPT-damaged replication forks (Figure 1B;
Figure S1C). This setup was combined with SILAC (Ong et al.,
2002) labeling, and we performed NCC-SILAC-MS in biological
triplicates to quantitatively compare the protein composition of
normal and damaged forks (Table S1). We identified more than
4,000 proteins across three independent replicates (Figures
S7A–S7C).
For an unbiased assessment of CPT-induced changes in the
replication fork proteome, we performed a Gene Ontology (GO)
analysis of the 10% most enriched or depleted proteins (Fig-
ure 1C). Proteins involved in the DNA damage response (DDR)
such as HR and DNA damage signaling were significantly en-
riched in CPT, verifying successful isolation of proteins surround-
ing CPT-induced seDSBs. In addition, we found enrichment of
DNA/RNAhelicases, likely reflecting inductionof replication-tran-
scription collision and R-loop formation caused by CPT-depen-
dent inhibition of transcription (Tuduri et al., 2009). The most
depleted categories included NHEJ, the repressive PRC1 com-
plex, and nuclear inner membrane proteins. While inspecting
the data for replication factors, we noticed a strongCPT-induced
skew between leading- and lagging-strand proteins. Leading-
strand proteins were moderately depleted, whereas lagging-
strand proteins were enriched in CPT (Figure S1D). Because
this might be a result of dormant origin firing to compensate for
CPT-induced fork slow-down (Haahr et al., 2016; Ray Chaudhuri
et al., 2012;Wang et al., 2014;Woodward et al., 2006), we carried
out a new round of NCC-SILAC-MS in the presence of the CDK2
inhibitor roscovitine to suppress new origin firing (Petermann
et al., 2010a) and normalize fork numbers (Figures 1D and 1E).Molecular Cell 81, 1084–1099, March 4, 2021 1085
Figure 1. Protein composition of broken replication forks
(A) SILAC-NCC-MS strategy for proteomics analysis of broken replication forks. Cells were released from a single thymidine block into mid-S phase and labeled
with biotin-dUTP (b-dUTP) in the absence (untreated [Unt]) or presence of CPT (1 mM) prior to NCC purification.
(B) Left: NCC pull-downs analyzed by western blotting. Unt samples were harvested immediately after b-dUTP labeling (0 h) or 2 h. Right: b-dUTP-labeled
S-phase cells show CPT-induced DNA damage (gH2AX and pRPAS33). An arrowhead indicates b-dUTP-negative cells (outside of S phase). Scale bar, 15 mm.
(C) GOanalysis of proteins recruited (top 10%based onH/L ratio) or depleted (bottom 10%based onH/L ratio) at CPT-damaged forks. All identified proteins were
used as background. p vvalue is shown with fold enrichment.
(D) Illustration of dormant origin firing in response to CPT and suppression of new origin firing by roscovitine (rosco).
(E) Experimental design for NCC-SILAC-MS using roscovitine to block CPT-induced dormant origin firing.
(F) GO analysis as in (C).
(G) Heatmap of replication and DDR factor enrichment, indicating the mean of three independent experiments. Not detected is indicated by gray coloring.
See also Figure S1.
ll
OPEN ACCESS ArticleRoscovitine did not affect the replication elongation rate or DNA
damage induction by CPT (Figures S1E and S1F), and a separate
NCC-SILAC-MS analysis showed that roscovitine treatment1086 Molecular Cell 81, 1084–1099, March 4, 2021alone did not substantially change fork composition (Figures
S1GandS7A–S7C). TheNCC-SILAC-MSanalysis of cells treated
with CPT and roscovitine identified more than 4,000 proteins
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OPEN ACCESSArticleacross threehighly concordant replicates (Figure 1E; FigureS7A–
S7C). A GO analysis also revealed CPT-induced enrichment for
HR repair and DNA damage signaling and depletion of interac-
tionswith nuclear innermembrane proteins in the presence of ro-
scovitine (Figure1F).However, replication factors andassociated
DNA mismatch repair (MMR) proteins were depleted when CPT
treatment was combined with roscovitine (Figure 1F), reflecting
moderate depletion of leading- and lagging-strand proteins in
this setting (Figure 1G). The observed CPT-induced enrichment
of lagging-strand factors is thus roscovitine sensitive (Figure 1G;
Figure S1D), consistent with trapping of newly fired dormant ori-
gins where primer elongation by polymerase delta (without CMG
interaction) establishes leading-strand replication (Aria and
Yeeles, 2018; Yeeles et al., 2017). When dormant origin firing is
blocked and similar numbers of replication intermediates are
compared, leading- and lagging-strand replication proteins are
overall depleted uponCPT treatment. This argues that the canon-
ical replication machinery is disassembled at a fraction of CPT-
damaged forks.
Distinct protein dynamics at broken and stalled
replication forks
Detailed inspection of the broken fork proteome revealed enrich-
ment of a large panel of DNA repair, fork-processing and check-
point-signaling factors (Figures S2A and S2B). This is not surpris-
ing because CPT induces a variety of replication problems, such
as fork reversal and transcription-replication collision, in addition
to fork breakage (Neelsen and Lopes, 2015). Thus, to pinpoint
specific factors responding to fork breakage, we carried out
NCC-SILAC-MS of stalled replication forks using a short high
HU dose to fully block DNA synthesis and promote fork reversal
without fork breakage (Petermann et al., 2010b; Figures S1E,
S2C, S2D, and S7A–S7C). Under these conditions, HU treatment
immediately blocked DNA synthesis (Figure S2E), consistent
with previous work showing that dormant origins do not fire
upon short exposure to high doses of HU (Dungrawala et al.,
2015). A GO analysis showed high enrichment of DDR processes
(Figure S2F) and a high overlap with previous analysis of
HU arrested forks by iPOND (Dungrawala et al., 2015; Fig-
ure S2G; Table S2). With the exception of PCNA unloading (Sirbu
et al., 2011), we saw no evidence of replisome disassembly in HU
(Figure S2H), suggesting that this is a CPT-specific response.
We identified three distinct classes of fork repair factors by
comparing the replication fork proteomes of HU- and CPT-
treated cells (Figures 2A and 2B). Class I factors recruited only
in CPT, class II factors recruited only in HU, and class III factors
showed enrichment in CPT and HU (Figure 2A). The latter high-
lights the commonality between CPT- and HU-induced re-
sponses, consistent with observations that ATR signaling and
replication fork reversal occur in response to both types of repli-
cation stresses (Ray Chaudhuri et al., 2012). Class I and II factors
are the most intriguing, revealing unique responses to CPT and
HU at a proportion of replication forks. Indeed, identification of
classic DSB signaling (ATM) and HR factors (CtIP) in class I (Ben-
simon et al., 2011; Sartori et al., 2007) confirms induction of repli-
cation-associated seDSBs upon CPT treatment (Chanut et al.,
2016; Huertas and Jackson, 2009). The role of PLK1 in this
response is unexpected and deserves further exploration.NHEJ factors, including Ku70/80 and DNA-PKcs were not en-
riched upon CPT or HU treatment, but RIF1 was lost from broken
forks. A substantial number of repair factors travel with the repli-
cation fork (Alabert et al., 2014) and are present at stressed repli-
cation forks without necessarily being enriched further (Fig-
ure 2B, red gradient fill color). In CPT, a set of those factors
(Rad18-SLF1-SLF2) involved in post-replication repair is selec-
tively depleted, suggesting that their function is adversary in
the face of a broken fork. Class II proteins include a group of
well-known proteins with functions in ubiquitin signaling at
DSBs (RNF168 and RNF169), including the BRCA1-A complex,
which antagonizes HR by suppressing DNA end resection (Cole-
man and Greenberg, 2011; Hustedt and Durocher, 2016). These
factors are not recruited to CPT-damaged forks in the absence
or presence of roscovitine (Figure S1H). These results indicate
that repair of broken replication forks is facilitated by recruitment
of ATM, PLK1, and CtIP (Chanut et al., 2016), whereas DSB-
associated ubiquitin signaling and the BRCA1-A deubiquitinase
complex are more prevalent at stalled forks.
TOP1 inhibition challenges chromatin assembly and
nuclear attachment
Consistent with the GO analysis (Figures 1C and 1F), a focused
view of more than 40 inner nuclear membrane (INM) and nuclear
pore complexes (NPCs) showed clear CPT-specific dissociation
of nascent chromatin from the INM compartment, in particular
lamins and NPCs (Figure 3A). These changes are likely to reflect
specific changes in engagement or proximity of replication forks
to the INM because the cytoplasmic components of the NPC did
not show a similar trend. The PRC1 complex was also lost from
CPT-treated forks, according to the GO analysis (Figure 1C), and
similar behavior was observed for histone H1, the PRC2 com-
plex, and the histone H2A.Z replacement variant (Figure 3B). In
contrast, these chromatin regulators were enriched at HU stalled
forks (Figure 3B). Under unperturbed conditions, these proteins
are recruited during chromatin restoration (Alabert et al., 2014) in
the hours after fork passage. Chromatin restoration and the
associated histone H4 deacetylation proceed in the presence
of HU (Annunziato, 1989; Sirbu et al., 2011; Figure S2C), but
NCC-pulse SILAC-MS showed that new histone H4 remained
hyperacetylated at CPT-damaged forks (Figure 1B; Figure S3A).
We also analyzed the methylation status of histone H4 lysine 20
(H4K20) because it is critical for the balance between HR and
NHEJ at canonical DSBs (Nakamura et al., 2019; Saredi et al.,
2016). However, H4K20 methylation was not altered by CPT
treatment; old histones were methylated uniformly at H4K20
(mainly di-methylated [me2]], >80%), whereas new histones
were unmethylated at H4K20 (H4K20me0) (Figure S3A). In
accordance, CPT treatment does not alter global H4K20 methyl-
ation levels in chromatin (Saredi et al., 2016). These data show
that the chromatin environments of stalled and broken forks
are highly distinct; chromatin maturation continues in the face
of fork stalling, whereas fork breakage somehow delays this
process.
To understand why chromatin maturation was delayed at
broken forks, we analyzed the overall abundance of histones
in nascent chromatin. For comparison, we also performed
NCC-SILAC-MS of cells treated short term with cycloheximideMolecular Cell 81, 1084–1099, March 4, 2021 1087
Figure 2. Protein dynamics in response to fork breakage and fork stalling
(A) Left: heatmap of replication and DDR factor enrichment at broken (CPT+Rosco/Rosco) and stalled (HU/Unt) replication forks. To normalize for fork numbers,
CPT+Rosco/Rosco data were used. The mean of three independent experiments is shown. Right: enrichment of DDR proteins across CPT and HU NCC-SILAC-
MS datasets. Broken forks, CPT+Rosco/Rosco; stalled fork, HU/Unt.
(B) Overview of DDR factor recruitment to broken forks (blue bars, CPT+Rosco/Rosco) and stalled forks (yellow bars, HU/Unt). The box gradient fill color indicates
enrichment at undamaged forks (red) over mature chromatin (blue), as illustrated on the right (Alabert et al., 2014). Well-established protein complexes (red lines),
functional groups (dotted line), and interactions (gray lines) are shown. Not detected (ND) is indicated by gray coloring.
See also Figure S2.
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Figure 3. Distinct chromatin environment at broken and stalled replication forks
(A and B) Heatmap showing enrichment of inner nuclear membrane (INM) proteins (A), nuclear pore complex (NPC; A), and chromatin regulators (B) at broken
(CPT+Rosco/Rosco) and stalled (HU/Unt) replication forks. The mean of three independent experiments is shown.
(C) Enrichment of canonical histones across all NCC-SILAC-MS data (see Figures S7A and S7B for details). Mean is shown with SEM; n = 3. CHX, cycloheximide.
(D) Left: the ratio of newly synthesized (new) and old recycled (old) histone H4 at replication forks isolated fromCPT- and CHX-treated cells. New and old histones
were analyzed by pulse-SILAC labeling followed by NCC-MS (Figure S3A). The CHX dataset is from Alabert et al. (2015). Mean is shown with SEM; n = 3 (CHX), 2
(CPT). Right: illustration of new and old histones in nascent chromatin.
See also Figure S3.
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Figure 4. ATM inhibition rewires the broken replication fork proteome toward a stalled fork response
(A) Experimental design of NCC-SILAC-MS analysis of ATM function at CPT-damaged forks (CPT+ATMi/CPT). The ATMi AZD0156 (250 nM) was added 5 min
before CPT (1 mM) treatment.
(legend continued on next page)
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OPEN ACCESSArticle(CHX) to block new histone biosynthesis (Mejlvang et al., 2014;
Figures S7A–S7C). In response to CPT, nucleosome occupancy
was reduced at replication forks almost to the same extent as
preventing new histone deposition with CHX (Figure 3C). How-
ever, although histone occupancy was reduced in response to
CPT and CHX, the relative ratio of new and old histones differed.
In response to CHX, parental histones were strongly enriched as
expected, but CPT did not dramatically alter the new/old ratio
(Figure 3D). Therefore, reduced nucleosome occupancy at
CPT-damaged forks reflects a defect in deposition of new and
old histones behind the fork. Indeed, we found that CPT treat-
ment resulted in gradual enrichment of histone H3.3 in global
chromatin (Figure S3B; Table S3), probably reflecting gap filling
during chromatin restoration (Ray-Gallet et al., 2011). Collec-
tively, these data argue that nucleosome occupancy is reduced
at CPT-damaged replication forks and that this, in turn, may
delay association of chromatin regulators involved in repression
(PRC1, PRC2, and histone H1).
Dissecting ATM function at broken replication forks
ATM, a master regulator of the DSB response, was recruited to
broken replication forks but not detected at HU stalled forks (Fig-
ures 2A and 2B). Consistent with this, CPT activates ATM
signaling (Shiloh, 2014), and ATM deficient cells are hypersensi-
tive to TOP1 inhibitors (Smith et al., 1989). To dissect how ATM
promotes repair and cell survival, we directly compared the
broken fork proteome in the absence and presence of ATM
signaling using a highly specific inhibitor (ATMi; AZD0156)
currently in clinical trials (NCT02588105). AZD0156 abrogated
ATM autophosphorylation in response to CPT more efficiently
than the commonly used ATMi KU55933 and reduced gH2AX,
phospho-RPA, and RPA accumulation in response to CPT but
not HU (Figures S4A–S4F). NCC-SILAC-MS identified more
than 4,000 proteins with high reproducibility across six biological
replicates (Figure 4A; Figures S7A–S7C) and revealed major re-
wiring of the broken fork proteome in the absence of ATM
signaling (Figure 4B).
INM proteins showed limited changes upon ATM inhibition,
whereas a panel of chromatin regulators, including PRC1, H3.3,
DNMT3a, and G9a/GLP-ZNF644-Wiz were suppressed by ATM
signaling. Most prominently, ATM inhibition caused massive
deregulation of factors involved in protein ubiquitination during
DSB repair, promoting recruitment of thepositiveH2Aubiquitina-
tion (H2A-Ub) regulators MDC1, RNF8, RNF168, RNF169, and
L3MBTL2 and expelling the negative regulator POH1 (Figure 4C;(B) Enrichment of DDR (left) and chromatin (right) proteins, shown as log2 SILAC
independent experiments is shown. NE, nuclear envelope.
(C) Enrichments of DDR proteins from (B), grouped according to function. Symbol
binding proteins.
(D and E) High-content microscopy of U-2-OS cells exposed to CPT or HU for 1 h
gH2AX and BRCA1 (D) or RPA (E).
(D) BRCA1 foci in gH2AX positive cells are shown relative to cells treatedwith CPT
dots and correspond to the mean of more than 1,092 cells. *p = 0.0303; NS, not
positive cells in Figure S4I.
(E) RPA intensity shown as mean (+), with whiskers indicating 10th–90th percentile
See the gating strategy for RPA-positive cells in Figure S4J.
(F) Correlation plot showing DDR proteins identified in NCC-SILAC-MS as indica
See also Figure S4.Figure S4G; Butler et al., 2012; Kakarougkas et al., 2013; Nows-
heen et al., 2018; Uckelmann and Sixma, 2017). Upon ATM inhi-
bition, we also found recruitment of UBQLN4, a negative regu-
lator of MRE11 (Jachimowicz et al., 2019), and the E3/E4
ubiquitin ligases UBE4A, which contribute to sustain K48- and
K63-linked ubiquitin chains at DSBs (Baranes-Bachar et al.,
2018). In addition, several factors otherwise preferentially en-
riched at stalled forks, such as FANCD2-I, BLM, and members
of the BRCA1-A complex (BRCA1, BRCC45, ABRAXAS,
RAP80, and MERIT40) were recruited to CPT-damaged forks
upon ATM inhibition (Figure 4C). The BRCA1-A complex limits
DNA end resection, and high-content microscopy confirmed
that BRCA1 recruitment to CPT-damaged forks is suppressed
by ATM signaling (Figure 4D; Figures S4H and S4I), consistent
with recent reports (Balmus et al., 2019). RAP80, a reader of
K63-ubiquitin chains, was among the most affected proteins in
the BRCA1-A complex (Figure 4C), as expected if enhanced
recruitment ofBRCA1-A is a response to deregulation of ubiquitin
signaling. The core NHEJ factors Ku70/80 and DNA-PKcs were
not recruited, but the two anti-HR factors RIF1 and REV7 accu-
mulated at broken forks upon ATM inhibition (Figure 4C; Setiapu-
tra and Durocher, 2019). This argues that ATM activity promotes
HR repair of broken replication forks in part by restricting protein
ubiquitination and, thereby, recruitment of anti-HR factors.
Importantly, this also explains the recent finding that deletion of
BRCA1-A complex components (BRCC45, ABRAXAS, RAP80,
MERIT40, and BRCC36) rescues sensitivity to TOP1 inhibitors
in ATM-deficient cells (Balmus et al., 2019).
Consistent with rewiring away from HR, RPA accumulation at
broken forks was suppressed by ATM inhibition, and, concomi-
tantly, the RPA binding proteins ETAA1, SMARCAL1, ATR, and
TONSL-MMS22Lwere lost (Figure 4C). High-content microscopy
confirmed that ATM signaling and CtIP-dependent end resection
were required for RPA accumulation at CPT-treated forks (Fig-
ure 4E; Figure S4J), as also reported by others (Balmus et al.,
2019; Chanut et al., 2016). A correlation analysis across DNA
repairproteins inourNCC-SILAC-MSdatashowed that theoverall
repair proteome shifted away from seDSB repair toward a stalled
fork composition when ATM kinase activity was inhibited (Fig-
ure 4F; Figure S4K). We thus hypothesize that HR repair is sup-
pressedat stalled forks through recruitment of theH2Aubiquitina-
tion machinery and the BRCA1-A complex, among others.
ATM inhibition significantly reduced restart of CPT-damaged
replication forks but was dispensable for restart of HU-
stalled forks (Figure 5A; Figure S5A). Upon ATM inhibition,ratios of CPT+ATMi (heavy) over CPT (light) (CPT+ATMi/CPT). The mean of six
size indicates the number of replicates in which a protein was identified. *, RPA
with or without ATMi added 5 min before. Pre-extracted cells were stained for
alone. Error bars indicate SEM; n = 3. Individualmeasurements are indicated by
significant by ratio-paired two-sided t test. See the gating strategy for gH2AX
s; from left, n = 3,858, 3,402, 3,398, 3,249, 8,946, 9,509, 8,525, and 8,068 cells.
ted. Pearson correlations (r) are shown.
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Figure 5. ATM and PLK1 suppress RNF168 recruitment and downstream accumulation of RAP80
(A) DNA fiber analysis of replication fork restart. Top: experimental design. Fork restart, fork arrest, and new origin firing were scored as shown in Figure S5A.
Bottom: percentage of labeled DNA tracks is shown as the mean, with error bars indicating SEM. Individual measurements are indicated by dots (CPT, n = 3; HU,
n = 2). From the left, **p = 0.0046, 0.0028, and 0.2658; NS, not significant by ratio-paired two-sided t test.
(B–D) High-content microscopy of RNF168 and RAP80 recruitment to CPT-induced DNA repair foci. U-2-OS cells were exposed to CPT for 1 h in the presence or
absence of ATMi (AZD0156) and PLK1 inhibitor (volasertib). In (D), cells were treatedwith control or RNF168 siRNAs for 48 h prior to drug treatment. Pre-extracted
cells were stained for gH2AX and RNF168 (B) or RAP80 (C and D). RNF168 or RAP80 foci in gH2AX-positive cells are shown relative to cells treated with CPT
alone. Error bars indicate SEM; n = 4 (B), n = 5 (C), n = 3 (D). Individual measurements are indicated by dots and correspond to the mean of more than 894 cells. A
representative experiment is shown in Figures S5B and S5C. *p < 0.05, **p < 0.01 by ratio-paired two-sided t test.
(E) Model illustrating suppression of H2A ubiquitination by ATM and PLK1 kinase activity at broken forks.
See also Figure S5.
ll
OPEN ACCESS ArticleRNF168 and RAP80 accumulated at CPT-induced repair foci
(Figures 5B and 5C; Figures S5B and S5C), consistent with our
NCC-SILAC-MS analysis (Figure 4C). RAP80 accumulation
was dependent on RNF168 (Figure 5D), arguing that RNF168-
dependent H2A ubiquitination facilitates BRCA1-A recruitment
via RAP80 binding to K63-ubiquitin chains. Because our NCC-
SILAC-MS data indicated that PLK1 is recruited to CPT-induced
seDSBs in an ATM-dependent manner (Figures 2A and 4C), we
also included the PLK1 inhibitor volasertib in these experiments.
Volasertib is a potent inhibitor of PLK1 but can also inhibit PLK2
and PLK3 at higher doses. Inhibition of PLK kinase activity
largely mimicked the effect of ATM inhibition on RNF168 and
RAP80 recruitment. Collectively, this argues that ATM and1092 Molecular Cell 81, 1084–1099, March 4, 2021PLK1 counteract toxic NHEJ by suppressing RNF168-depen-
dent H2A ubiquitination and BRCA1-A recruitment (Figure 5E).
Novel HR factors required for repair of CPT damaged
replication forks
Analysis of protein enrichment across all NCC-SILAC-MS data-
sets identified a number of novel putative fork repair proteins
(Figure 6A; Table S4). To validate this resource, we focused on
two factors, NDRG3 (N-myc downstream-regulated gene 3)
and UBAP2 (ubiquitin-binding associated protein 2), identified
previously as putative phosphorylation targets of ATM/ATR (Bal-
mus et al., 2019; Boeing et al., 2016; Matsuoka et al., 2007;
Stokes et al., 2007). NDRG3 was predominantly cytosolic and
Figure 6. NDRG3 and UBAP2 are new HR factors required for CPT resistance
(A) Overview of putative novel DDR factors identified by NCC-SILAC-MS. Recruitment to broken forks (blue, CPT+Rosco/Rosco) and stalled forks (yellow, HU/
Unt) is indicated as in Figure 2B. A red dotted line encircles ATM/ATR substrates (Boeing et al., 2016; Matsuoka et al., 2007; Stokes et al., 2007). Factors were
selected based on the enrichment of a higher than 0.3 log2 SILAC ratio and being putative ATM/ATR targets (Table S4).
(B) Colony formation analysis. Left: siRNA depletion of NDRG3 in U-2-OS cells treated with CPT (50 nM) for 24 h. Mean with SEM, n = 3. Right: CRISPRi depletion
of UBAP2 in U-2-OS cells treated with CPT (50 nM) for 24 h. Mean with SEM, n = 3. *p < 0.05, **p < 0.01 by ratio-paired two-sided t test.
(legend continued on next page)
ll
OPEN ACCESSArticle
Molecular Cell 81, 1084–1099, March 4, 2021 1093
ll
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CPT treatment, whereas UBAP2 was present in the nuclear
and cytosolic fraction regardless of CPT treatment (Figure S6A).
Depletion of NDRG3 or UBAP2 by small interfering RNA (siRNA)
or CRISPRi reduced cell viability in response to CPT and led to
enhanced accumulation of gH2AX (Figures 6B and 6C; Figures
S6B–S6F). Consistent with this, NDRG3 and UBAP2 depletion
impaired HR repair of canonical DSBs (Figure 6D) in the well-es-
tablished DR-GFP HR reporter assay (Pierce et al., 1999). These
data identify NDRG3 andUBAP2 as novel HR regulators required
for CPT resistance, validating our collection of NCC-SILAC-MS
data as a resource for pinpointing novel DDR candidates.
To address NDRG3 function in further detail, we asked
whether this novel HR factor works up- or downstream of DNA
end resection and Rad51 loading. CPT-induced phosphorylation
of RPA and RPA accumulation on chromatin were not altered by
absence of NDRG3 (Figure 6E; Figure S6G), suggesting that DNA
end resection was normal. However, RAD51 loading at CPT-
damaged forks was decreased substantially in NDRG3-depleted
cells (Figure 6F; Figure S6H), and this was not due to changes in
the cell cycle or RAD51 protein expression (Figures S6B and
S6F). Because NDRG3 was also recruited to HU-arrested repli-
cation forks (Figure 6A), we monitored RAD51 accumulation in
response to HU. In this setting, NDRG3was also required for effi-
cient RAD51 loading (Figure S6I). This indicates that NDRG3 is a
novel HR factor facilitating RAD51 loading at different replication
damage intermediates.
DISCUSSION
In this work, we provide a comprehensive proteomics character-
ization of replication fork responses to TOP1 inhibitors, widely
used in the clinic to treat colorectal, lung, ovarian, cervical, and
pancreatic cancers (Thomas and Pommier, 2019). This coordi-
nated replication fork proteome analysis, including six novel
large datasets, provides unprecedented insights into the
composition of replication forks challenged by seDSBs and to-
pological stress. This is a valuable resource to track the behavior
of known replication, repair, and chromatin proteins and, impor-
tantly, allows identification of novel repair factors, as we demon-
strate for NDRG3 and UBAP2. Our NCC-SILAC-MS approach
identifies a high number of chromatin and nuclear architectural
proteins, revealing an unexpected difference in the environment
of CPT- and HU-damaged forks, spanning from nucleosome oc-
cupancy to nuclear membrane interactions. Comparing the ‘‘re-
pairome’’ of CPT- and HU-challenged forks, we identify three(C) High-content microscopy of gH2AX in siRNA-transfected U-2-OS cells expose
gH2AX-positive cells, gated as shown in Figure S6F. Error bars indicate SEM, n =
more than 1,871 cells.
(D) HR efficiency measured in DR-GFP U-2-OS reporter cells. The HR efficiency is
**p < 0.01 by ratio-paired two-sided t test.
(E) High-content microscopy of RPA in siRNA-transfected U-2-OS cells exposed
gH2AX-positive cells, gated as shown in Figure S6C. Error bars indicate SEM, n =
more than 1,871 cells.
(F) High-content microscopy of RAD51 foci. Left: representative images of RAD
gH2AX-positive cells relative to control siRNA treatment. Mean with error bars sho
of more 449 cells. A representative experiment is shown in Figure S6H. siRNA-tr
See also Figure S6.
1094 Molecular Cell 81, 1084–1099, March 4, 2021classes of fork repair factors, with classes I and II being specific
to broken and stalled forks, respectively. Class I included ATM,
the master regulator of DSB responses required for genome
repair and cell survival in response to CPT. Upon ATM inhibition,
NCC-SILAC-MS revealed that the broken fork proteome was re-
wired toward that of stalled forks and anti-HR activities. These
pervasive changes argue that ATM promotes HR-dependent
fork restart by concomitantly promoting DNA end resection
and suppressing canonical DSB-associated ubiquitin signaling.
This comprehensive study of replication fork responses to
TOP1 inhibitors highlights the strength of NCC-SILAC-MS for
defining replication fork repairomes and revealing the complex
changes in chromatin environment resulting from fork damage.
In previous work, iPOND-SILAC-MS technology, involving 5-
ethynyl-2’-deoxyuridine (EdU)-labeling and click-it chemistry
(in place of b-dUTP labeling used in NCC), has been instrumental
in characterizing the response to fork stalling (Dungrawala et al.,
2015; Mukherjee et al., 2019). One study analyzed CPT-treated
cells by iPOND and non-quantitative proteomics (Ribeyre
et al., 2016) but identified less than 30 proteins that show little
overlap with the large number of DDR factors enriched at CPT-
challenged forks in our dataset. This probably reflects the impor-
tance of taking a quantitative proteomics approach, as high-
lighted by a comparison across published iPOND and NCC
data (Cortez, 2017). NCC-SILAC-MS was developed specifically
to comprehensively define the proteome of replication forks and
newly assembled chromatin relative to post-replication mature
chromatin (Alabert et al., 2014, 2015). To robustly trap chromatin
components, NCC includes stronger protein-DNA crosslinking
as compared to iPOND, explaining why more proteins are iden-
tified byNCC-SILAC-MS. NCC and iPOND thus are complemen-
tary technologies, and intersection of NCC-SILAC-MS (Alabert
et al., 2014) and iPOND-SILAC-MS (Dungrawala et al., 2015) da-
tasets previously allowed identification of a high-confidence
mammalian replication fork proteome (Cortez, 2017). Similarly,
overlapping the NCC-SILAC-MS (this work) and iPOND-SILAC-
MS (Dungrawala et al., 2015) analysis of forks stalled by short
HU treatment identifies a high-confidence stalled replication
fork proteome, including 52 proteins, 26 of which are not known
DNA repair factors (Figure S2G; Table S2).
The chromatin and nuclear environments of replication forks
challenged by HU and CPT are dramatically different. As chro-
matin restoration proceeds, we envision that the environment
of stalled forks is rather heterogeneous and largely determined
by the local chromatin landscape (e.g., repressive or active chro-
matin). In contrast, active and CPT-damaged forks ared to CPT for 1 h. Mean intensity relative to control siRNA (siControl) is shown for
4. Individual data points are indicated by dots and correspond to the means of
shown as percent of control siRNA. Mean is shown with SEM, n = 3. *p < 0.05,
to CPT for 1 h. Mean intensity relative to control siRNA (siControl) is shown for
3. Individual data points are indicated by dots and correspond to the means of
51 and gH2AX. Scale bar, 10 mm. Right: bar diagram showing RAD51 foci in
wing SEM, n = 3. Data points are indicated by dots and correspond to themean
ansfected U-2-OS cells were exposed to CPT for 3 h.
Figure 7. Model of proteome dynamics at
broken replication forks
Detailed model illustrating ATM function in protein
recruitment at broken forks (this work) integrated
with repair functions established in the literature
(see text for references). ATM is recruited to broken
forks, where it recruits PLK1 and promotes CtIP-
dependent DNA end resection to facilitate HR
repair. In parallel, ATM and PLK1 suppress H2A
monoubiquitination and K63-linked poly-ubiquiti-
nation and, thereby, recruitment of BRCA1-A. ATM
also promotes accumulation of POH1, a K63-spe-
cific deubiquitinase, and restricts accumulation of
NHEJ factors such as SMCHD1, RIF1, and REV7.
ll
OPEN ACCESSArticleembedded in highly acetylated nascent chromatin. In response
to CPT, nucleosome occupancy was reduced in a manner
affecting new and old histones similarly and maintaining the bal-
ance of H4K20me0 and H4K20me2 specific to replicated chro-
matin. This could be a consequence of seDSB processing
or topological stress interfering with nucleosome assembly
(Hammond et al., 2017; Hauer et al., 2017). The levels of the
variant histone H3.3 increased during recovery from CPT,
consistent with gap filling by HIRA (Ray-Gallet et al., 2011).
CPT treatment also strongly reduced the interactions of repli-
cating chromatin with the INM and nuclear pores, suggesting
that seDSBs or topological stress triggers dissociation of forks
from the nuclear envelope. This was largely independent of
ATM signaling, suggesting that it originates from topological
stress, low chromatin compaction, and/or interference with pro-
cesses such as gene gating at nuclear pores (Bermejo et al.,
2011). Mutation in nuclear envelope proteins in the premature
aging diseases Hutchinson-Gilford progeria syndrome and
restrictive dermopathy causes DNA damage and genome insta-
bility (Carrero et al., 2016). Comprehensive characterization of
CPT-induced changes in the fork proteome provides an entry
point to mechanistically address how interactions with the nu-
clear periphery are involved in fork progression and repair.
There was a substantial overlap in the repairome of CPT- and
HU-challenged forks (class III), many of which are involved in
ATR-dependent checkpoint signaling and RPA binding, arguing


























20MolecuConsistent with this, these replication
checkpoint factors are also recruited to
replicating chromatin upon induction of
DNA ICLs (R€aschle et al., 2015). The
CPT-specific factors included only ATM,
CtIP, and PLK1. The requirement of ATM
and CtIP in seDSBs repair is well estab-
lished (Balmus et al., 2019; Chanut et al.,
2016; Sartori et al., 2007; Smith et al.,
1989), but the specific ATM-dependent
recruitment of PLK1 to this type of
lesion was unexpected. PLK1 can restrict
NHEJ in mitosis by phosphorylation of
53BP1 (Benada et al., 2015) and XRCC4
(Terasawa et al., 2014). Local PLK1 activity
at broken forks may thus prevent delete-us NHEJ. Consistent with this idea, PLK1 inhibition sensitizes
lls to CPT analogs (Zuco et al., 2015), and PLK1 is also re-
uited to ICLs in replicating chromatin, where NHEJ is unwar-
nted (R€aschle et al., 2015). We find that PLK1 operates down-
ream of ATM to suppress the H2A ubiquitination response and
CA1-A recruitment. ATM inhibition diminished RPA accumu-
ion at broken forks, consistent with previous work showing
M-dependent DNA end resection at seDSBs (Balmus et al.,
19; Chanut et al., 2016). Strikingly, ATM not only promoted
via positive regulation, but it actively restricted accumulation
a large group of proteins involved in NHEJ and protein ubiqui-
ation, including REV7, SMCHD1, BRCA1-A, UBQLN4,
F168, RNF169, RNF8, and Rad18. Many of these factors
re enriched at HU-stalled forks (RNF168, RNF169, BRCA1-
and Rad18), suggesting that ATM signaling extensively re-
res the broken fork proteome to reduce activities that may
t to limit HR at stalled forks (Figures 4F and 7). Many of these
ctors were also recruited during ICL repair in replicating Xeno-
s chromatin, including RNF168, Rad18, and BRCA1-A
€aschle et al., 2015), whereas the MRE11-RAD50-NBS1
RN) complex and CtIP were not enriched at ICL repair sites.
F8 and RNF168 regulate ubiquitin signaling at canonical
Bs, where they contribute to recruitment of NHEJ and HR fac-
rs in a complex fashion (Uckelmann and Sixma, 2017). At ca-
nical DSBs, ATM-dependent phosphorylation of MDC1 and
2AX is upstream of the ubiquitination response (Kolas et al.,
07). In contrast, ATM and PLK1 signaling restrict this responselar Cell 81, 1084–1099, March 4, 2021 1095
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DNA end resection at seDSBs normally ‘‘deactivates’’ the DSB
ubiquitination response but that ATM inactivation disables this
feedback loop and leads to hyperubiquitin signaling despite
reduced gH2AX (Figure 7). Our results argue that the BRCA1-A
complex is recruited erroneously to seDSBs via RAP80 binding
to excess ubiquitin chains that accumulate in the absence of
ATM signaling (Kim et al., 2007; Sobhian et al., 2007; Wang
et al., 2007). This, in turn, explains why genetic deletion of
BRCA1-A rescues DNA end resection and CPT sensitivity in
ATM-null cells (Balmus et al., 2019).
The NCC-SILAC-MS resource also identifies novel fork repair
factors, advancing our understanding of replication stress re-
sponses and providing new potential targets for drug discovery.
We identify a panel of uncharacterized factors enriched at CPT-
and HU-challenged forks, a high proportion of which are putative
ATM/ATR targets, consistent with a DDR function. Functional
analysis revealed NDRG3 and UBAP2 as novel HR-promoting
factors. NDRG3 is required for efficient Rad51 loading and cell
survival in response to CPT. NDRG3 is expressed ubiquitously,
and in testes, NDRG3 is localized to the outer layers of seminif-
erous epithelium (Zhao et al., 2001), suggesting that it could be
involved in HR at damaged forks and during meiotic recombina-
tion in spermatogenesis. NDRG3 upregulation correlates with
poor prognosis in prostate and liver cancer (Lee et al., 2016)
and has been linked to drug resistance (Du et al., 2017; Yu
et al., 2019), which could be linked to an HR function. Our results
also suggest that mutations in the H2A ubiquitination machinery
may promote resistance to ATM inhibitors and provide important
insights relevant to ongoing clinical investigations of PLK1 inhib-
itors in cancer therapy (Liu et al., 2017). We thus suggest that
integration of replication fork proteomics with cancer genomics
can be explored as an entry point to identify resistance mecha-
nisms and cancer vulnerabilities that can be exploited in
treatment.
Limitations of study
In this study, we perform comprehensive proteomics profiling of
damaged replication forks using NCC-SILAC-MS. The repair-
ome of CPT-induced broken replication forks is highly distinct
from proteomics analyses of replication forks challenged by
nucleotide depletion or DNA ICLs (Dungrawala et al., 2015; Mu-
kherjee et al., 2019; R€aschle et al., 2015). The response to CPT-
induced fork breakage is also distinct from fork collapse trig-
gered by ATR inhibition in combination with HU, which is permis-
sive for NHEJ (Dungrawala et al., 2015), as indicated by recruit-
ment of DNA-PKcs and KU70-KU80. Fork breakage induced by
other genotoxic agents (e.g., PARP inhibitors) will likely share
some but not all features with CPT-induced fork breakage,
because most agents challenge replisome stability though a
number of mechanisms. In addition to fork breakage, TOP1 in-
hibitors introduce topological stress at the replication fork and
enhance the likelihood of replication-transcription collision. The
response to these stresses is also captured in our study of the
CPT-specific fork repairome, which is critical to integrate these
molecular data with the clinical response. We focus our analysis
on replication forks exposed for a short time to CPT to capture
the initial response to seDSBs. Building on these findings, we1096 Molecular Cell 81, 1084–1099, March 4, 2021expect that a time-resolved analysis of the CPT response and
fork recovery could inform further on repair dynamics in the
future.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell culture
U-2-OS and HeLa S3 described previously (Alabert et al., 2014) were grown in Dulbecco’s modified Eagle’s medium (GIBCO) con-
taining 10% fetal bovine serum (HyClone), 1% penicillin/streptomycin and drugs for selection. All cell lines used in this study tested
negative forMycoplasma contamination. SILAC-labeling of cells was performed as described previously (Alabert et al., 2014). Briefly,
HeLa S3 cells in spinners were grown in SILAC medium depleted for arginine and lysine (Thermo Scientific RPMI 1640 Medium) and
supplemented with dialyzed FBS (#26400-036 Invitrogen), MEM non-essential amino acid mix (#11140 Invitrogen), Glutamax
(#35050-038 Invitrogen), 66 mg l1 of arginine and 100 mg l1 of lysine (SIGMA). Heavy medium was complemented with heavy
lysine and arginine (Cambridge Laboratory number CNLM-291-0.25, number CLM-2265-0). Cells were maintained for eight to
nine divisions in heavy or light medium before NCC analysis. Catalytically dead Cas9 (dCAS9) expressing U-2-OS cells were sorted
based on mCherry expression level (Figure S6D) and used for CRISPRi.
METHOD DETAILS
Synchronization and drug treatment
HeLa S3 cells were synchronized at the G1/S border by single thymidine block (2 mM, 17 h) and released into fresh media containing
deoxycytidine (24 mM) for 3 h as described (Alabert et al., 2014). The following drugs were used: 1 mMCPT (Sigma), 3mMHU (Sigma),
100 mg/ml CHX (Sigma), ATMi; 250 nM AZD0156 (Active Biochem), ATRi; 300 nM AZ20 (MedChemExpress (MCE)), CDKi; 25 mM ro-
scovitine (Sigma), PLK1i; 1 mM Volasertib (Selleckchem).
Nascent chromatin capture (NCC)
NCC was performed as described previously (Alabert et al., 2014) with the following modifications. For biotin–dUTP labeling, cells
were incubated for 5 min in a hypotonic buffer (50 mM KCl and 10 mM HEPES) containing biotin–dUTP and resuspended in fresh
cell culture medium containing biotin–dUTP. Labeling and drug treatment is detailed in Figure S6A. Cells were fixed 15 min in 2%
formaldehyde and crosslinking was stopped by addition of glycine to a final concentration of 1% and incubation for 5 min at
room temperature. Nuclei were mechanically isolated in a sucrose buffer (0.3 M sucrose, 10 mM HEPES–NaOH at pH 7.9, 1% Triton
X-100 and 2 mMMgOAc), and chromatin was solubilized by sonication in a Diagenode Bioruptor at 4◦C in sonication buffer (10 mM
HEPES–NaOH at pH 7.9, 100 mM NaCl, 2 mM EDTA at pH 8, 1 mM EGTA at pH 8, 0.2% SDS, 0.1% sodium sarkosyl and 1 mM phe-
nylmethylsulphonyl fluoride; Bioruptor setting: High, 28 cycles of 30 s sonication and 90 s pause). Biotinylated chromatin fragments
were purified on streptavidin-coated magnetic beads (MyC1 Streptavidin beads) by overnight end-over-end rotation at 4◦C and five
stringent washes (10 mM HEPES–NaOH at pH 7.9, 100 mM NaCl, 2 mM EDTA at pH 8, 1 mM EGTA at pH 8, 0.1% SDS, and 1 mM
phenylmethylsulphonyl fluoride). For SILAC analysis, nascent andmature samples weremixed in the last wash. To release chromatin
and reverse the crosslink, beads were boiled in LSB for 40 min at 100◦C, including a brief vortex and short spin every 10 min to pre-
vent drying.
Mass spectrometry
NCC samples were in-gel digested with trypsin as previously described (Alabert et al., 2014). Tryptic peptides were acidified with
orthophosphoric acid and subjected to strong cation exchange (SCX) fractionation, using a polySULFOETHYL A column on an Ul-
timate 3000 Dionex LC system (Thermo Fisher Scientific). Mobile phase A consisted of 5mM KH2PO4 in 10% acetonitrile at pH 3;
mobile phase B was 5 mM KH2PO4, 1 M KCl, and 10% acetonitrile, pH 3. The flow rate was constant at 200 ml/min. Fractions
were collected at 1min intervals. SCX fractions were dilutedwith an equal volume of 0.1%TFA and spun onto StageTips as described
(Rappsilber et al., 2003). Peptides were eluted in 20 ml 80% acetonitrile in 0.1% TFA and concentrated down to less than 4 ml by vac-
uum centrifugation to evaporate acetonitrile. Mass spectrometry analyses were performed on a Q Exactive Mass spectrometer
(Thermo Fisher Scientific), coupled with Ultimate 3000 RSLC nano Systems (Thermo Fisher Scientific). Peptides were loaded directly
onto a spray emitter analytical column (75 mm inner diameter, 8 mm opening, 250 mm length; New Objectives) packed with C18 ma-
terial (ReproSil-Pur C18-AQ 3 mm;DrMaisch GmbH) using an air pressure pump (Proxeon Biosystems) (Ishihama et al., 2006). Mobile
phase A consisted of water and 0.1% formic acid, and mobile phase B consisted of 80% acetonitrile and 0.1% formic acid. The
gradient used was 180 min. The peptides were loaded onto the column at a flow rate of 0.5 ml/min and eluted at a flow rate of
0.2 ml/min according to the following gradient: 2%–40% buffer B in 180 min, then to 95% in 16 min. MS1 spectra were recorded
at 70,000 resolution with scan range 350–1400 m/z. Precursor ions with top 10 intensity and charge state R 2 were isolated ande3 Molecular Cell 81, 1084–1099.e1–e6, March 4, 2021
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corded with a resolution of 17,500, isolation window of 2.0 m/z, maximum injection time of 60 ms and AGC target of 5e4. Dynamic
exclusion was enabled with single repeat count and 60 s exclusion duration.
NCC raw file processing
NCC-related mass spectrometry raw files were processed using MaxQuant 1.5.8.3. The following default MaxQuant search param-
eters were used: MS1 tolerance for the first Andromeda search: 20 ppm, MS1 tolerance for the main Andromeda search: 4.5 ppm,
FTMS MS2 match tolerance: 20 ppm, ITMS MS2 match tolerance: 0.5 Da, Variable modifications: acetylation of protein N-termini,
oxidation of methionine, Fixed modifications: carbamidomethylation of cysteine, Decoy mode set to reverse, Minimum peptide
length: 7 and Max missed cleavages set to 2. The following non-default settings were used: In group-specific parameters, match
type was set to ‘‘No matching’’ and SILAC labels were set to Arg6 and Lys8. The ‘‘Re-quantify’’ option was enabled. Under global
parameters, the minimum ratio count was set to 1 and ‘‘Discard unmodified counterpart peptide’’ was disabled. Also in global pa-
rameters, writing of large tables was disabled. Canonical and isoform protein sequences were downloaded from UniProt (Bateman,
2019) on 29th March 2017, considering only reviewed SwissProt entries that were part of the human proteome. To simplify quanti-
tation of core histones, 29 redundant core histone sequences were removed from the database, as described before (Alabert
et al., 2014).
NCC data analysis
Data analysis was performed in R 3.4.1. The scripts used to process these data are available in GitHub (https://github.com/
Rappsilber-Laboratory/NCC). Protein fold-changes were extracted from the MaxQuant proteinGroups file. Proteins labeled as con-
taminants and reverse hits and those only identified by amodification site were discarded. Normalized SILAC ratios were considered
for downstream analysis, log2 transformed andmedian-normalized. For each protein, themean SILAC ratio and the standard error of
themean were calculated across the three replicates (six replicates in the case of NCC-ATMi), considering only SILAC ratios that had
been detected with at least two ratio counts. The complete NCC-SILAC proteomics dataset is presented in Table S1. Interphase
chromatin probabilities (Kustatscher et al., 2014) are included in the table to facilitate identification of new candidate DDR and repli-
cation factors as described (Alabert et al., 2014).
Gene ontology (GO) analysis
Gene ontology enrichment analysis for NCC-SILAC-MS assays was performed using DAVID 6.8 (Huang et al., 2009b, 2009a). Only
proteins detected in two ormore experiments were considered. Enrichment of terms from the GO aspects biological process, cellular
component and molecular function, and enrichment of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and protein
domains (InterPro) were calculated, using all identified proteins as background. Terms enriched with a p value lower than 0.05 were
considered statistically significant. Ribosomal proteins are very abundant and can be found as contaminants in NCC samples regard-
less of whether replication forks are stalled or stressed. We therefore excluded GO terms related to ribosomes.
Histone PTM analysis
NCC isolated histones were separated in a 16% gel and processed with either propionic anhydride (Figure S3B) or deuterated-6
acetic anhydride (Figure 3D; Figure S3A) as described before with minor modifications (Völker-Albert et al., 2018a). For LC-MS/MS
purposes, desalted peptides were injected in an Ultimate 3000 RSLCnano system (Thermo), separated in a 15-cm analytical col-
umn (75 mm ID home-packed with ReproSil-Pur C18-AQ 2.4 mm from Dr. Maisch) with a 50-min gradient from 5 to 60% acetonitrile
in 0.1% formic acid. The effluent from the HPLC was directly electrosprayed into a LTQ-Orbitrap mass spectrometer XL (Fig-
ure S3B) or a Q Exactive HF (Figure 3D; Figure S3A) (Thermo). For LTQ-Orbitrap measurements, the instrument was operated
in data dependent mode to automatically switch between full scan MS and MS/MS acquisition. Survey full scan MS spectra
(from m/z 300 – 2000) were acquired in the Orbitrap with resolution R = 60,000 at m/z 400 (after accumulation to a ‘target value’
of 500,000 in the linear ion trap). The six most intense peptide ions with charge states between 2 and 4 were sequentially isolated
to a target value of 10,000 and fragmented in the linear ion trap by collision induced dissociation (CID). All fragment ion spectra
were recorded in the LTQ part of the instrument. For all measurements with the Orbitrap detector, 3 lock-mass ions from ambient
air were used for internal calibration as described before (Olsen et al., 2005). Typical MS conditions were: spray voltage, 1.5 kV; no
sheath and auxiliary gas flow; heated capillary temperature, 200C; normalized CID energy 35%; activation q = 0.25; activation
time = 30 ms.
For Q Exactive HF measurements, the mass spectrometer was operated in the PRM mode to identify and quantify the light and
heavy (K8R10) versions of the H4 4-17 peptide carrying one, two or three naturel acetyl groups6. In this mode, themass spectrometer
automatically switched between one survey scan and 6 MS/MS acquisitions of the m/z values described in the inclusion list contain-
ing the precursor ions, modifications, and fragmentation conditions. Survey full scan MS spectra (from m/z 260–760) were acquired
with resolution R = 30,000 at m/z 400 (AGC target of 3x106). The ions from the inclusion list were sequentially isolated to a target value
of 2x105 (isolation window 1.3 m/z), and fragmented at 27% normalized collision energy. Typical mass spectrometric conditions
were: spray voltage, 1.5 kV; no sheath and auxiliary gas flow; heated capillary temperature, 250C; ion selection threshold,
33.000 counts. Raw data were analyzed using Skyline or QuanBrowser as described previously (Feller et al., 2015; Völker-AlbertMolecular Cell 81, 1084–1099.e1–e6, March 4, 2021 e4
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analysis were done with GraphPad Prism 8.
siRNA transfection
siRNA transfection was performed with RNAiMax reagent (Invitrogen) according to the manufacturer’s protocol. siRNA sequences
(Ambion, Thermo Fisher scientific) were: siNDRG3#1, 50-CCAAUGUUGUGGACAUUAUtt-30; and siNDRG3#2, 50-GCCUUGUGCU
CAUUAAUGUtt-30; negative control siRNA (NC1), 50-UAACGACGCGACGACGUAAtt-30; siNBS1, 50-GUACGUUGUUGGAAG
GAAAtt-30; siCtIP, 50-GCUAAAACAGGAACGAAUCtt-30; siUBAP2#1, 50-CCUAGCUAAUAAUCCAUAUtt-30; siUBAP2#2, 50-GCAUU
GAUCUGGUAGCCUUtt-30.
HR assay
DR-GFP-U-2-OS cells were described previously (Nakamura et al., 2019). Briefly, 3.753 105 cells/well were seeded on 6-well plates.
After 24 h, the cells were transfected with siRNAs and incubate another 24 h before transfection with I-SceI (pCBASce) and RFP
expression vectors. 24 h after transfection, cells were washed and replated on 100-mm dishes. Flow cytometric analysis to quantify
the presence of GFP-positive cells was performed 2 days later on a FACSCalibur using Cellquest Pro software (BD Biosciences). For
each sample, 30,000 cells were analyzed and the percentage of GFP-positive cells out of total transfected RFP positive cells was
calculated as HR repaired cells.
Colony formation
U-2-OS cells were transfected with siRNA and 24 h later cells were trypsinised and seeded in technical triplicates of 300 to
10,000 cells. After 24 h, CPT was added for 24 h at the indicated concentrations. Cells were then cultured in fresh medium
for 7–15 days before fixation and staining with MeOH/Crystal Violet. Colony formation efficiency was determined by manual col-
ony counting and normalized to non-drug treated control. Each data point (biological replicate) represents the mean of technical
triplicates.
DNA fiber assay
DNA fiber assay was performed as described previously (Mejlvang et al., 2014) with the following modifications. U-2-OS or HeLa-S3
cells were labeled with 150 mM IdU (Sigma-Aldrich) and 150 mM CldU (MP Biomedicals) as shown in the figures. 2 mL of cells resus-
pended in ice-cold PBS was deposited on amicroscope slide and incubated with 7 mL of spreading buffer (200 mM Tris-HCl, pH 7.5,
0.5% SDS, and 50 mM EDTA) for 3 min. The slides were tilted 15 to stretch the DNA fibers. After fixation with methanol/acetic acid
(3:1), DNA was denatured with 2.5 M HCl and blocked (PBS with 1% BSA and 0.1% Triton X-100) before staining with primary an-
tibodies, anti-CldU (eurobio), anti-IdU (BD) and corresponding secondary antibodies conjugated with Alexa Fluor 488 (Chicken anti-
Rat IgG) or 568 (Goat anti-Mouse IgG). To enhance the IdU-Alexa Fluor 568 signal, cells were additionally incubated Alexa Fluor 568
(Donkey anti-Goat IgG). ssDNA was detected by anti-ssDNA (MAB3034, Millipore) and corresponding secondary antibodies conju-
gated with Alexa 647 (Invitrogen). Images were captured on a DeltaVision system (Applied Precision) and analyzed with softWoRx
6.5.2 software (Applied Precision).
Immunofluorescence and high-content microscopy
Immunofluorescencewas performed as described previously (Nakamura et al., 2019). Briefly, U-2-OS cells were grown on glass cov-
erslips or 96-well plates and either directly fixed in 4% paraformaldehyde for 10 min or washed in cytoskeleton buffer (CSK; 10 mM
PIPES pH 7, 100 mM NaCl, 300 mM sucrose, 3 mMMgCl2), pre-extracted for 5 min with CSK/0.5% Triton X-100 (on ice) and rinsed
with CSK and phosphate buffered saline before fixation in 4% paraformaldehyde for 10 min. For B-dUTP incorporation, images were
acquired using a DeltaVision system (Applied Precision) and analyzed by Volocity image analysis software (PerkinElmer). For high-
content quantitative analysis, fluorescence imageswere acquired using anOlympus ScanR high-contentmicroscope and processed
on the ScanR analysis software (Olympus).
sgRNA cloning
sgRNA cloning was performed as described in Gilbert et al. (2014). The oligos were annealed in annealing buffer (200 mM potassium
acetate, 60 mM HEPES-KOH pH 7.4, 4 mM magnesium acetate) and ligated into BstXI + BlpI digested pU6-sgRNA-EF1a-puro-
T2A-BFP.
Lentiviral transduction
HEK293FT cells were co-transfectedwith pU6-sgRNA- EF1a-puro-T2A-BFP or pHR-SFFV-KRAB-dCas9-P2A-mCHERRY and pAX8
and pCMV-VSV using a standard calcium phosphate protocol. The viral supernatant was collected 72 h after HEK293FT transfection
and used for transduction. Transduction was performed in presence of polybrene at 8 mg/ml. 24 h after transduction with sgRNA-
encoding lentiviral plasmids, puromycin was added at 1 mg/ml for U-2-OS cells.e5 Molecular Cell 81, 1084–1099.e1–e6, March 4, 2021
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Statistics were analyzed with GraphPad Prism 8. All statistics were evaluated by either independent or paired two-tailed Student’s t
test and two-tailed Mann–Whitney U-test. Pearson’s correlation and Student’s t test were performed under the assumption of
normality. The exact sample sizes (n) used to calculate statistics are provided in the figure captions. p values are provided in the figure
legends and captions.Whiskers indicate 10th–90th percentiles, and outliers are plotted as individual points in box-and-whisker plots.
All experiments were reproduced with similar results a minimum two times.Molecular Cell 81, 1084–1099.e1–e6, March 4, 2021 e6
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Figure S1. Proteomic analysis of broken replication forks, Related to Figure 1 
(A) High-content microscopy of CPT-induced gH2AX and new DNA synthesis. Top, experimental 
design for optimization of CPT treatment for NCC, aiming to induce high levels of DNA damage 
while maintaining DNA synthesis. EdU positive cells were defined by gating on mean EdU intensity 
and DAPI (insets). Bottom, scatter plots show total intensity of EdU (blue) and gH2AX (red) in EdU 
positive cells. (B) Analysis of biotin-dUTP (B-dUTP) incorporation under conditions used for SILAC-
NCC-MS (CPT/Unt) analysis of CPT-treated cells as detailed in in Figure 1A. HeLa-S3 cells were 
labelled 20 min (CPT) or 15 min (Unt) with B-dUTP in the presence or absence of CPT treatment 
(see Figure 1A) before pre-extraction and immunofluorescence analysis. The mean intensity in B-
dUTP positive cells is shown with SEM, n=3. Individual data points are indicated by dots and 
correspond to the mean of >142 cells.  (C) Experimental design for Figure 1B. (D) Enrichment of 
core replication factors. Leading and lagging strand associated proteins are separated as in Figure 
1G. Black bars indicate mean. (E) Top, experimental design for NCC western blot analysis of CPT, 
HU, and roscovitine (Rosco) treated cells. Bottom, NCC pulldown analyzed by western blotting. (F) 
DNA fiber analysis of cells treated with CPT and Rosco. Mean ratio of IdU/CldU length are shown 
with SEM, n=3 independent experiments; from left P=0.0207, 0.0111, NS, not significant (P=0.2173), 
ratio paired two-sided t-test. Data points are indicated by dots and correspond to the mean of 50 
CIdU-IdU tracks from three independent experiments. (G) Top, experimental design for NCC-
SILAC-MS analysis of cell treated with and without Rosco (Rosco/Untreated). Bottom, enrichment 
of DDR proteins, given as the mean of three independent experiments. (H) Correlation plot showing 
replication and DDR proteins identified in CPT+Rosco/Rosco and CPT/Unt NCC-SILAC-MS. The 
proteins identified in ≤ 1 replicates in CPT/Unt are shown on the right. Pearson correlation (r) of 



















Figure S2. Protein composition of broken and stalled replication forks, Related to Figure 2 
(A), (B) Enrichment of replication and DDR proteins, considering only high confidence factors 
identified in ³2 NCC-SILAC-MS experiments of (CPT+Rosco/Rosco) (A) and (CPT/Unt) (B). 
Enrichments are given as the mean log2 SILAC ratios of three independent experiments. (C) Top, 
experimental design for NCC western blot analysis of stalled replication forks. Cells were labelled 
15 min with B-dUTP and treated with 3 mM HU as indicated. Cell cycle profiles are shown to illustrate 
that HU blocks DNA replication. Bottom, NCC pulldown analyzed by western blotting. (D) Top, 
experimental design for NCC-SILAC-MS analysis of HU stalled replication forks (HU/Unt). Bottom, 
enrichment of replication and DDR proteins as in (A). (E) Top, experimental design for EdU 
incorporation upon HU treatment. Bottom left, high-content microscopy of EdU. The mean intensity 
in EdU positive cells is shown with SEM. n=3 independent experiments. NS, not significant by ratio 
paired two-sided t-test. Bottom right, one representative experiment is shown. The bars indicate 
mean. From left n=2052, 2305, and 1909. (F) GO analysis of the proteins recruited to stalled forks 
(top 10 % enriched based on H/L ratio). (G) Top, overlap between NCC-SILAC-MS and iPOND-
SILAC-MS (Dungrawala et al., 2015) analyses of HU stalled replication forks. The number of 
proteins enriched at stalled replication forks above histone H4 (Log2 HU/Unt SILAC ratio > H4) are 
shown. Given the technical differences, SILAC ratios are not directly comparable. We thus use 
histone H4, robustly identified by both methods, to set a threshold for protein enrichment at stalled 
replication forks. 52 factors are identified by NCC and iPOND in cells treated 30 min with HU (see 
Table S2). Bottom, high confidence DDR proteins recruited to stalled replication forks (identified by 
both NCC and iPOND). Enrichment in iPOND-SILAC-MS in mouse ES cells (Mukherjee et al., 2019) 
is included for comparison. (H) Enrichment of leading and lagging strand associated proteins at 
broken (CPT+Rosco/Rosco) and stalled (HU/Unt) replication forks. Symbol size indicates number 

















Figure S3. Histone PTM analysis, Related to Figure 3 
(A) Top, design of NCC-pulse SILAC-MS experiment to track acetylation (bottom left) and 
methylation (bottom right) on new (light color) and old (dark color) histone H4 in CPT (orange) and 
untreated (blue) cells. Different modification states are shown as the percentage total peptide 
identified. The H4 amino acid 4–17 (aa4–17) peptide contains four potential acetylation sites (K5, 
K8, K12, and K16). (Un) Unmodified; (ac) acetylated; (ac2) diacetylated; (ac3) triacetylated; (ac4) 
quadriacetylated. me0, unmethylated; me1, mono-methylated; me2, di-methylated; me3, tri-
methylated. Bars show the mean of two independent experiments (n=2), with individual 
measurements indicated by dots. (B) Left, experimental design for analysis of histones SILAC-NCC-
MS. Right, the ratio of histone H3.3/H3.1 are shown. NCC, NCC pulldown of nascent (0 h) and 
mature (2 h) chromatin (B-dUTP labelled chromatin); Total, bulk chromatin. The mean is shown with 




Figure S4. Dissecting ATM function at broken replication forks, Related to Figure 4  
(A) Left, experimental design for analyzing ATM dependent responses to CPT and HU. Right, gating 
strategy to identify S phase cells (EdU positive) is shown. RS, replication stress. (B)-(F) High-
content microscopy of pATM-S1981 (B), gH2AX (C), pRPA-S33 (D), RPA (E) and EdU (F) in EdU 
positive cells is shown relative to mock/no RS. ATMi, 10 μM KU-55933 or 250 nM AZD0156. ATRi, 
300 nM AZ20. U-2-OS cells were treated with CPT according to the scheme developed for NCC-
SILAC-MS shown in (A). (E, right panel) **, P=0.0058 by ratio paired two-sided t-test. (G) 
Comparison of SILAC Log2 ratios between the indicated protein categories (BRCA1-A complex, 
factors promoting DDR ubiquitination) and all other proteins. ***, P<0.001; ****, P<0.0001 by Mann-
Whitney U test. (H) High-content microscopy of gH2AX accumulation upon CPT or HU treatment, 
as control for Figure 4D, E. U-2-OS cells were exposed to 1 µM CPT or 3 mM HU for 1 h. The cells 
were pre-extracted and analyzed by immunofluorescence. ATMi (AZD0156) was added 5 min before 
treatment with CPT or HU. The intensity in gH2AX positive cells is shown with SEM. n=3 independent 
experiments. *, P=0.0312; NS, not significant by ratio paired two-sided t-test. Data points are 
indicated by dots and correspond to the mean of >3937 cells. (I) Gating strategy for gH2AX positive 
cells. CPT induced gH2AX positive cells are highly overlapped with EdU positive (S phase) cells. (J) 
Gating strategy for RPA positive cells quantified in Figure 4E. (K) GO analysis of the proteins 
recruited to CPT treated forks upon inhibition of ATM signaling (top 10 % enriched based on H/L 






























Figure S5. Regulation of H2A ubiquitination by ATM and PLK1 at broken replication forks, 
Related to Figure 5  
(A) Representative images to illustrate identification of new origins, restarted forks and arrested 
forks in Figure 5A. Cells were incubated CIdU (green) followed by IdU (red). Scale bar, 15 µm. (B, 
C) Representative experiments from Figure 5B, C. Mean is shown (+) with whiskers indicate 10-90 
percentile; From left in (B), n = 2805, 1960, 2518, and 2254 cells. From left in (C), n = 2117, 1879, 



















Figure S6. NDRG3 is required for RAD51 regulation upon CPT, Related to Figure 6 
(A) Western blot analysis of NDRG3 and UBAP2 localization. HeLa S3 cells were treated as 
indicated (CPT, 1 µM for 1 h) and nuclear (nu) and cytosolic (sol) extract were harvested for western 
blotting as described (Jasencakova et al., 2010). CAF1 p150 was used as a fractionation control. 
One representative experiment is shown of three biological replicates. Asterisk indicates non-
specific bands. (B) Western blot analysis of NDRG3 and RAD51 in siRNA transfected cells. (C) 
Western blot analysis of UBAP2 in siRNA transfected U-2-OS cells. Asterisk indicates non-specific 
bands. (D)Top, flow cytometry analysis of dCAS9-mCherry expression. Bottom, validation of 
UBAP2-targeted sgRNA by immunofluorescence. Pre-extraction was performed before 
immunofluorescence analysis. Scale bar, 10 µm. (E) High-content microscopy of gH2AX. The cells 
were exposed to 1 µM CPT for 1 h before pre-extraction and immunofluorescence analysis. Mean 
intensity in gH2AX positive cells relative to control sgRNA is shown. Error bars indicate SEM., n=4. 
*, significant by ratio paired two-sided t-test. (F, G) High-content microscopy of siRNA transfected 
U-2-OS cells treated with 1 µM CPT for 1 h prior to pre-extraction and analysis by 
immunofluorescence. (F) Gating strategy to identify gH2AX positive cells. (G) Analysis of phospho-
RPA(Ser33) in gH2AX positive cells. Bars show mean with SEM, n=3. Data points are indicated by 
dots and correspond to the mean of >1391 cells. (H) Representative experiment related to Figure 
6F. Mean is shown (+) with whiskers indicate 10-90 percentile; from left, n = 608, 616, 563. (I) High-
content microscopy of RAD51 foci. siRNA transfected U-2-OS cells treated with 3 mM HU for 2 h 
prior to pre-extraction and analysis by immunofluorescence. Bar-diagram showing the number of 
RAD51 foci in gH2AX positive cells relative to control siRNA treatment. Mean with error bars showing 




















Figure S7. NCC-SILAC-MS data set resource, Related to Figure 1-6 
(A) Experimental design for NCC-SILAC-MS experiments. Published Nascent/Mature data 
(Alabert et al., 2014) were reprocessed and normalized similar to the other data sets for comparison. 
(B) Number of identified proteins in NCC-SILAC-MS experiments across all replicates, 
considering only SILAC ratios detected by 2 or more ratio counts. (C) Scatter plots comparing Log2 
SILAC ratios between replicates. The Pearson correlation of replication and DDR proteins (green) 
and for all identified proteins (grey) is shown, illustrating reproducibility.  
 
 
 
 
